respiratory infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Screening criteria: 1. Aged =65 years; 2. Patients hospitalised for acute lower respiratory tract infections, which include acute tracheo-bronchitis, community-acquired pneumonia, acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease, bronchiectasis co-infections, and interstitial fibrosis co-infections; 3. Hospitalisation in this institution. Inclusion criteria: patients whom at least one dimension of the EQ-5D-5L was present and impaired (assessed at level >1) at the time of discharge from the hospital after meeting the above screening and exclusion criteria.
Exclusion criteria
Exclusion criteria: 1. Aged >100 years; 2. Unable to co-operate in completing the questionnaire and follow-up for various reasons (severe cognitive impairment, deafness, non-Chinese speaking, etc.); 3. Chronic infections including tuberculosis, fungal infections of the lungs, bacterial lung abscess, etc; 4. Acute heart attack (within 1 month), unstable angina pectoris, uncontrolled arrhythmia, active stage of infective endocarditis or pericarditis, severe aortic stenosis, uncontrolled heart failure, uncontrolled hypertension (resting systolic blood pressure >180mmHg, diastolic blood pressure >100mmHg), suspected aneurysm entrapment; 5. Acute pulmonary embolism or pulmonary infarction, lower extremity deep vein thrombosis; uncontrolled asthma, respiratory failure; history of spontaneous pneumothorax in the last 1 year or uncontrolled pneumothorax; 6. Previous psychiatric abnormality or under psychiatric treatment; previous personality disorder, mental retardation, brain injury, or brain disease 7. Persons with comorbid neuromuscular and other systemic disorders or other severe movement disorders such as joint deformities, diseases, or severe spinal joint pains that interfere with physical mobility 8. Who have participated in other rehabilitation studies within the past 6 months 9. Current participation in other interventional clinical trials (participation in observational clinical trials may be included); 10. Comorbid serious underlying disease with a life expectancy of survival of <1 year; 11. Prolonged bed rest; 12. Death during hospitalisation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of life;emotional disorder; | — |
Secondary
| Measure | Time frame |
|---|---|
| death;re-hospitalization;Ability to perform daily activities;cognitive ability;nutrition;fall;immune;time to assessment; | — |
Countries
China
Contacts
Beijing Hospital